Clinical Trial

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

Name: A Study of Ivonescimab in People With Non-Small Cell Lung Cancer — clinical trial record (NCT07594522)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The researchers are doing this study to find out whether ivonescimab after receiving standard stereotactic body radiotherapy (SBRT) is an effective treatment in people with Non-Small Cell Lung Cancer (NSCLC).

Trial Details

NCT Number	NCT07594522
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Non-Small Cell Lung Cancer
Enrollment	36 participants
Start Date	2026-05-12
Primary Completion	2028-05-12 (estimated)
Study Completion	2028-05-12 (estimated)
Updated on ClinicalTrials.gov	2026-05-18